1231P Phase I study to evaluate the safety, tolerability, and efficacy of VCN-01 in combination with durvalumab (MEDI4736) in subjects with recurrent/metastatic squamous cell carcinoma of the head and neck (R/M HNSCC)

Autor: M. Jove, I. Brana, M. Oliva Bernal, A. Hernando-Calvo, C. Erasun Lecuona, J.D. Assaf Pastrana, M. Bazan Peregrino, A. Mato-Berciano, M.V. Maliandi, S. Torres-Manjon, J. Martinez de Villareal, F.X. Real, P.G. Nuciforo, R. Alemany, G. Capella, E. Blasi, C. Blasco, M. Cascallo Piqueras, R. Mesia Nin
Rok vydání: 2022
Předmět:
Zdroj: Annals of Oncology. 33:S1112
ISSN: 0923-7534
Databáze: OpenAIRE